Drug Profile
Research programme: sirolimus-eluting coronary balloon - Micell Technologies
Alternative Names: Drug-eluting coronary balloon - Micell TechnologiesLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Micell Technologies
- Class Lactones; Macrolides; Polyenes; Pyridines
- Mechanism of Action MTOR protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Vascular disorders
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Vascular-disorders in USA (Intracoronary, Implant)
- 18 Jul 2014 Early research is ongoing in USA
- 12 Jan 2009 Early research in Vascular disorders in USA (Intracoronary)